Compared with other agents tested for cancer imaging like antibodies [36] and nanoparticles [44, 46]⁠, peptides such as Hsp70-TPP offer several advantages such as smaller size, lower production costs, lower immunogenicity and toxicity, higher tumor penetration, and faster body clearance [26, 37]. This evidence concerns the gene HSPA1A and cancer.